Other projects that have aimed to detect CTC include “Cancel the cancer,” which targeted the epithelial cell adhesion molecule (EpCAM) biomarker (iGEM Fatih-Medical, 2012), and “cell in CELL” by DUT China A in 2019. This evidence concerns the gene EPCAM and cancer.